Stuttgart, Germany

Philipp Wagner

USPTO Granted Patents = 24 

 

Average Co-Inventor Count = 4.4

ph-index = 8

Forward Citations = 115(Granted Patents)


Location History:

  • Stuttgart, DE (2018 - 2024)
  • Tuebingen, DE (2022 - 2024)

Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Philipp Wagner's Contributions to Cancer Immunotherapy

Introduction: Philipp Wagner, a prominent inventor based in Stuttgart, Germany, has made significant strides in the field of cancer immunotherapy, holding an impressive portfolio of 24 patents. His innovative approaches to peptide technology have the potential to revolutionize treatment options for ovarian cancer and other malignancies.

Latest Patents: Among his latest inventions is focused on "Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers." This groundbreaking patent describes therapeutic methods that utilize peptides, proteins, nucleic acids, and cells for cancer treatment. The invention highlights tumor-associated T-cell peptide epitopes, which, either alone or in combination with other peptides, can function as active pharmaceutical ingredients in vaccine compositions aimed at stimulating anti-tumor immune responses. Additionally, the technology facilitates the stimulation of T cells ex vivo for later transfer to patients. This innovative work underscores the role of peptides, bound to molecules of the major histocompatibility complex (MHC), as targets for antibodies, soluble T-cell receptors, and other binding molecules.

Career Highlights: Philipp Wagner is currently affiliated with Immatics Biotechnologies GmbH, an organization dedicated to advancing cancer immunotherapy. His prolific patenting activity is a testament to his dedication to research and development in biotechnology.

Collaborations: Throughout his career, he has collaborated with esteemed colleagues, including Heiko Schuster and Hans-Georg Rammensee. Their joint efforts reflect a commitment to advancing cancer research and therapeutic strategies.

Conclusion: Philipp Wagner stands as a leading figure in the realm of immunotherapy, driving innovations that hold significant promise for cancer treatment. His contributions not only enhance our understanding of cancer biology but also offer hope for improved patient outcomes through cutting-edge therapeutic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…